IWC
AZN icon

Integrated Wealth Counsel’s AstraZeneca AZN Stock Holding History

Integrated Wealth Counsel’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$5K Hold
90
– – 0.01% 187
2016
Q3 		$6K Buy
+90
New +$5.88K 0.01% 175

Other funds holding AZN

Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
EIP
Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return
BIM
BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Integrated Wealth Counsel's AZN Position: Q4 2016 in Review

Integrated Wealth Counsel held its AstraZeneca (AZN) position steady in Q4 2016 at 90 shares worth $5K. The position accounts for 0.01% of the portfolio, ranked #187.

Integrated Wealth Counsel first reported a position in AZN in Q3 2016 and has held it in 2 quarters since. The position peaked at $6K in Q3 2016. 450 funds tracked by Wall St. Rank hold AZN as of Q4 2016.

  • Integrated Wealth Counsel held 90 shares of AstraZeneca worth $5K as of Q4 2016.
  • Integrated Wealth Counsel left its AstraZeneca share count unchanged in Q4 2016.
  • AstraZeneca made up 0.01% of Integrated Wealth Counsel's portfolio in Q4 2016, its #187 holding.
  • Integrated Wealth Counsel first reported a position in AstraZeneca in Q3 2016 and has held it in 2 quarters since.
  • Integrated Wealth Counsel's AstraZeneca position peaked at $6K in Q3 2016.
  • 450 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2016.

Based on Integrated Wealth Counsel's 13F filing for Q4 2016, filed 6 Feb 2017.